Payment overview · 2025
General Payments
$211.89
4 reported records · 2 companies
Healthcare provider profile · identity verified
Raj Rao, M.D
Allopathic & Osteopathic Physicians|General Practice · HARRISVILLE, MI · NPI 1144526252
Verified facts
What the public records show
CMS Open Payments records show Raj Rao, M.D received $211.89 in general payments during 2025 across 4 reported records.
AstraZeneca Pharmaceuticals LP accounted for 90.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 128 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LOKELMA as an associated drug or biological on 6897 records involving 4326 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Lokelma by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Symbicort by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $192.17 | 90.7% | 3 | 2025 |
| Globus Medical, Inc. | Unresolved — no canonical attribution shown | $19.72 | 9.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $211.89 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $175.07 | 2 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $67.17 | 2 | 2025 |
Source payment records
|
|||||
| MODULUS Normalized: modulus |
Device | Globus Medical, Inc. | $19.72 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
128 | 37 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | LOKELMA open payments reported associated product |
CMS Open Payments — General Payments 6897 supporting records · 4326 recipient NPIs · example record 1206131624 |
Lokelma · 2024 Exact normalized brand match · 1 Part D row |
24 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 637 | 89 |
| Levothyroxine Sodium | Levothyroxine Sodium | 613 | 127 |
| Simvastatin | Simvastatin | 507 | 121 |
| Gabapentin | Gabapentin | 467 | 81 |
| Losartan Potassium | Losartan Potassium | 463 | 119 |
| Atorvastatin Calcium | Atorvastatin Calcium | 392 | 86 |
| Pantoprazole Sodium | Pantoprazole Sodium | 383 | 96 |
| Eliquis | Apixaban | 367 | 58 |
| Metoprolol Succinate | Metoprolol Succinate | 313 | 74 |
| Nifedipine Er | Nifedipine | 253 | 80 |
| Potassium Chloride | Potassium Chloride | 245 | 45 |
| Tamsulosin Hcl | Tamsulosin Hcl | 235 | 59 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 226 | 77 |
| Diclofenac Sodium | Diclofenac Sodium | 225 | 76 |
| Furosemide | Furosemide | 222 | 60 |
| Sertraline Hcl | Sertraline Hcl | 222 | 34 |
| Buspirone Hcl | Buspirone Hcl | 212 | 31 |
| Allopurinol | Allopurinol | 193 | 51 |
| Meloxicam | Meloxicam | 192 | 48 |
| Glimepiride | Glimepiride | 188 | 56 |
| Tramadol Hcl | Tramadol Hcl | 182 | 47 |
| Metoprolol Tartrate | Metoprolol Tartrate | 181 | 46 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 180 | 52 |
| Carvedilol | Carvedilol | 178 | 40 |
| Trazodone Hcl | Trazodone Hcl | 178 | 42 |
| Mirtazapine | Mirtazapine | 167 | 38 |
| Pregabalin | Pregabalin | 160 | 31 |
| Metformin Hcl | Metformin Hcl | 158 | 45 |
| Jardiance | Empagliflozin | 157 | 20 |
| Clopidogrel | Clopidogrel Bisulfate | 154 | 43 |
| Amlodipine Besylate | Amlodipine Besylate | 145 | 49 |
| Entresto | Sacubitril/Valsartan | 141 | 20 |
| Escitalopram Oxalate | Escitalopram Oxalate | 138 | 25 |
| Finasteride | Finasteride | 137 | 38 |
| Montelukast Sodium | Montelukast Sodium | 134 | 34 |
| Bumetanide | Bumetanide | 133 | 32 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 131 | 30 |
| Farxiga | Dapagliflozin Propanediol | 128 | 37 |
| Xarelto | Rivaroxaban | 127 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 124 | 20 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 122 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 121 | 44 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 118 | 42 |
| Duloxetine Hcl | Duloxetine Hcl | 116 | 26 |
| Pioglitazone Hcl | Pioglitazone Hcl | 115 | 30 |
| Lorazepam | Lorazepam | 114 | 30 |
| Ezetimibe | Ezetimibe | 113 | 34 |
| Lisinopril | Lisinopril | 113 | 30 |
| Spironolactone | Spironolactone | 113 | 34 |
| Famotidine | Famotidine | 107 | 32 |
| Divalproex Sodium | Divalproex Sodium | 104 | 24 |
| Ibuprofen | Ibuprofen | 102 | 36 |
| Hydrochlorothiazide | Hydrochlorothiazide | 101 | 32 |
| Omeprazole | Omeprazole | 101 | 38 |
| Levetiracetam | Levetiracetam | 100 | 15 |
| Pravastatin Sodium | Pravastatin Sodium | 99 | 24 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 95 | 12 |
| Methylprednisolone | Methylprednisolone | 90 | 72 |
| Fluoxetine Hcl | Fluoxetine Hcl | 88 | suppressed |
| Ozempic | Semaglutide | 86 | 17 |
| Doxycycline Hyclate | Doxycycline Hyclate | 85 | 66 |
| Gemfibrozil | Gemfibrozil | 84 | 28 |
| Trulicity | Dulaglutide | 83 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 81 | 44 |
| Amitriptyline Hcl | Amitriptyline Hcl | 80 | 22 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 77 | 14 |
| Myrbetriq | Mirabegron | 75 | 11 |
| Prednisone | Prednisone | 75 | 46 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 72 | 18 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 72 | 21 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 72 | 17 |
| Quetiapine Fumarate | Quetiapine Fumarate | 72 | 16 |
| Sucralfate | Sucralfate | 72 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 71 | 34 |
| Hydralazine Hcl | Hydralazine Hcl | 71 | 21 |
| Ventolin Hfa | Albuterol Sulfate | 71 | 25 |
| Paroxetine Hcl | Paroxetine Hcl | 70 | 15 |
| Propranolol Hcl | Propranolol Hcl | 67 | 18 |
| Azithromycin | Azithromycin | 66 | 56 |
| Oxybutynin Chloride | Oxybutynin Chloride | 66 | 13 |
| Zolpidem Tartrate | Zolpidem Tartrate | 66 | 17 |
| Nystatin | Nystatin | 65 | 26 |
| Tizanidine Hcl | Tizanidine Hcl | 63 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 61 | 18 |
| Protonix | Pantoprazole Sodium | 61 | suppressed |
| Atenolol | Atenolol | 59 | 11 |
| Dapagliflozin | Dapagliflozin Propanediol | 57 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 56 | 14 |
| Topiramate | Topiramate | 56 | 14 |
| Baclofen | Baclofen | 55 | suppressed |
| Clonazepam | Clonazepam | 55 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 55 | 17 |
| Ondansetron Odt | Ondansetron | 53 | 25 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 52 | 16 |
| Ropinirole Hcl | Ropinirole Hcl | 52 | 15 |
| Tolterodine Tartrate | Tolterodine Tartrate | 51 | suppressed |
| Aripiprazole | Aripiprazole | 50 | 14 |
| Digoxin | Digoxin | 50 | 17 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 49 | suppressed |
| Levofloxacin | Levofloxacin | 46 | 31 |
| Alendronate Sodium | Alendronate Sodium | 44 | 14 |
| Enalapril Maleate | Enalapril Maleate | 44 | 12 |
| Meclizine Hcl | Meclizine Hcl | 43 | 13 |
| Permethrin | Permethrin | 43 | 32 |
| Sumatriptan Succinate | Sumatriptan Succinate | 42 | suppressed |
| Lovastatin | Lovastatin | 40 | 13 |
| Alprazolam | Alprazolam | 39 | suppressed |
| Carbamazepine | Carbamazepine | 39 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 39 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 39 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 38 | suppressed |
| Fenofibrate | Fenofibrate | 38 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 38 | 24 |
| Warfarin Sodium | Warfarin Sodium | 38 | suppressed |
| Fluconazole | Fluconazole | 37 | 24 |
| Paliperidone Er | Paliperidone | 37 | suppressed |
| Januvia | Sitagliptin Phosphate | 36 | suppressed |
| Amoxicillin | Amoxicillin | 35 | 27 |
| Clonidine | Clonidine | 35 | suppressed |
| Chlorthalidone | Chlorthalidone | 34 | 13 |
| Invokana | Canagliflozin | 34 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 33 | suppressed |
| Methotrexate | Methotrexate Sodium | 33 | suppressed |
| Acyclovir | Acyclovir | 32 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 32 | 16 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 32 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 32 | suppressed |
| Nitroglycerin | Nitroglycerin | 32 | 25 |
| Metformin Hcl Er | Metformin Hcl | 31 | suppressed |
| Prilosec | Omeprazole Magnesium | 31 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 30 | 12 |
| Clindamycin Hcl | Clindamycin Hcl | 29 | 21 |
| Bupropion Xl | Bupropion Hcl | 28 | suppressed |
| Risperidone | Risperidone | 28 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 26 | suppressed |
| Memantine Hcl | Memantine Hcl | 26 | 13 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 25 | suppressed |
| Etodolac | Etodolac | 24 | suppressed |
| Levemir | Insulin Detemir | 24 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 24 | suppressed |
| Cephalexin | Cephalexin | 23 | 15 |
| Creon | Lipase/Protease/Amylase | 23 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 22 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 22 | suppressed |
| Cilostazol | Cilostazol | 20 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 20 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 20 | suppressed |
| Lamotrigine | Lamotrigine | 20 | suppressed |
| Levemir Flexpen | Insulin Detemir | 20 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 20 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 19 | suppressed |
| Carisoprodol | Carisoprodol | 19 | suppressed |
| Olanzapine | Olanzapine | 19 | suppressed |
| Vraylar | Cariprazine Hcl | 19 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 18 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 18 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 18 | suppressed |
| Rytary | Carbidopa/Levodopa | 18 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 18 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 18 | suppressed |
| Diazepam | Diazepam | 17 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 17 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 17 | 14 |
| Primidone | Primidone | 17 | suppressed |
| Scopolamine | Scopolamine | 17 | suppressed |
| Sotalol | Sotalol Hcl | 17 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 16 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 16 | suppressed |
| Enulose | Lactulose | 16 | suppressed |
| Glipizide Er | Glipizide | 16 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 16 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 16 | suppressed |
| Sulfasalazine | Sulfasalazine | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 15 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 15 | suppressed |
| Nabumetone | Nabumetone | 15 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 15 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 15 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 15 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 15 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 14 | 14 |
| Tiotropium Bromide | Tiotropium Bromide | 14 | suppressed |
| Azathioprine | Azathioprine | 13 | suppressed |
| Dantrolene Sodium | Dantrolene Sodium | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 13 | suppressed |
| Loperamide | Loperamide Hcl | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Sumatriptan | Sumatriptan | 13 | suppressed |
| Tirosint-Sol | Levothyroxine Sodium | 13 | suppressed |
| Valsartan | Valsartan | 13 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Gemtesa | Vibegron | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Probenecid | Probenecid | 12 | suppressed |
| Ropinirole Er | Ropinirole Hcl | 12 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 12 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 11 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 11 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Naproxen | Naproxen | 11 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 11 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 11 | 11 |
| Telmisartan | Telmisartan | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $211.89 · 4 records | AstraZeneca Pharmaceuticals LP | AIRSUPRA, BREZTRI, MODULUS | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error